Authors : Priya Singh; Dr. Jasmeet Singh

Volume/Issue : Volume 10 - 2025, Issue 8 - August

Google Scholar : https://tinyurl.com/a95mau42

Scribd : https://tinyurl.com/3stdsdne

DOI : https://doi.org/10.38124/ijisrt/25aug078

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : The rising global incidence of type 2 diabetes has increased the demand for safe, effective, patient-compliant alternatives to traditional antidiabetic medications. This study presents the development and evaluation of Ayurvedic antidiabetic gummies as a next-generation herbal supplementation. A comprehensive polyherbal gummy was developed using standardized extracts of Gymnema sylvestre, Momordica charantia, Trigonella foenum-graecum, Syzygium cumini, Curcuma longa, and Ocimum sanctum with careful selection of gelling agents and natural sweeteners for palatable, effective tasting gummies. The gummie was then phytochemically profiled utilizing HPTLC and LC-MS for accurate analysis of components. In vitro antidiabetic assays (α-amylase and α-glucosidase inhibition) were performed as well as DPPH scavenging for antioxidant activity in conjunction with the in viv antidiabetic potential in streptozotocin-induced diabetic rats over 21 days with continued safety studies, organ histopathology and analysis of preliminary human trial data for changes in fasting blood glucose, and HbA1c. The formulated gummies showed excellent physicochemical stability, palatability, and compliance. Phytochemical analysis confirmed the retention of key bioactives post-processing. The in vitro assays demonstrated significant enzyme inhibition and antioxidant activity. In vivo, the gummies reduced fasting glucose levels, improved insulin sensitivity, and showed no hepatic or renal toxicity. Human participants showed a reduction in fasting glucose and HbA1c over 60 days with no reported adverse effects.

Keywords : Ayurvedic Formulation, Antidiabetic Gummies, Herbal Supplements, Polyherbal Synergy, Nutraceuticals, Type 2 Diabetes, Phytochemical Analysis, in Vitro Enzyme Inhibition, in Vivo Efficacy , Functional Foods.

References :

1. Mohammad Karim A. Principles and biomedical applications of self-assembled peptides: potential treatment of type 2 diabetes mellitus. Pharmaceutics. 2024 Nov 12;16(11):1442.
2. Otvos Jr L, Wade JD. Big peptide drugs in a small molecule world. Frontiers in Chemistry. 2023 Dec 7;11:1302169.
3. HAMEED S, KUMAR P, PRAKASH V, KUMAR M, DIKSHIT H. Efficacy and Safety of Linagliptin and Insulin in Patients of Type 2 Diabetes Mellitus with Grade 3-5 Chronic Kidney Disease in a Tertiary Care Hospital. Journal of Clinical & Diagnostic Research. 2021 Aug 1;15(8).
4. Bakshi H, Nagpal M, Singh M, Dhingra GA, Aggarwal G. Treatment of psoriasis: a comprehensive review of entire therapies. Current drug safety. 2020 Jul 1;15(2):82-104.
5. Anselmo AC, Mitragotri S. An overview of clinical and commercial impact of drug delivery systems. Journal of Controlled Release. 2014 Sep 28;190:15-28.
6. Motala AA, Pirie FJ, Rauff S, Bacus HB. Cost-effective management of diabetes mellitus. Ethnicity & Disease. 2006 Apr 1;16:79-84.
7. Meetoo D, Allen G. Understanding diabetes mellitus and its management: an overview. Nurse Prescribing. 2010 Jul;8(7):320-6.
8. Arokiasamy P, Salvi S, Selvamani Y. Global burden of diabetes mellitus. InHandbook of global health 2021 Feb 5 (pp. 1-44). Cham: Springer International Publishing.
9. Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to diabetes mellitus. Diabetes: an old disease, a new insight. 2012 Dec 30:1-1.
10. Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics. 2015 Aug;33(8):811-31.
11. Ramzan S, Timmins P, Hasan SS, Babar ZU. Cost analysis of type 2 diabetes mellitus treatment in economically developed countries. Expert Review of Pharmacoeconomics & Outcomes Research. 2019 Jan 2;19(1):5-14.
12. Williams R. The economics of diabetes care: a global perspective. International textbook of diabetes mellitus. 2015 Apr 17:1113-24.
13. Khatib OM, Oussama MN. Guidelines for the prevention, management and care of diabetes mellitus. World Health Organization. 2006;2008:978-2.
14. Shah VN, Garg SK. Managing diabetes in the digital age. Clinical Diabetes and Endocrinology. 2015 Dec 1;1(1):16.
15. Mustapha FI, Azmi S, Manaf MR, Hussein Z, Mahir NJ, Ismail F, Aizuddin AN, Goh A. What are the direct medical costs of managing Type 2 Diabetes Mellitus in Malaysia. Med J Malaysia. 2017 Oct 1;72(5):271-7.
16. Doyle G, O'Donnell S, Quigley E, Cullen K, Gibney S, Levin-Zamir D, Ganahl K, Müller G, Muller I, Maindal HT, Chang WP. Patient level cost of diabetes self-management education programmes: an international evaluation. BMJ open. 2017 Aug 1;7(5):e013805.
17. Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, Davies J, Vollmer S. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes care. 2018 May 1;41(5):963-70.
18. Williamson EM, Liu X, Izzo AA. Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals. British Journal of Pharmacology. 2020 Mar;177(6):1227-40.
19. Nicoletti M. Nutraceuticals and botanicals: overview and perspectives. International Journal of Food Sciences and Nutrition. 2012 Mar 1;63(sup1):2-6.
20. Chopra AS, Lordan R, Horbańczuk OK, Atanasov AG, Chopra I, Horbańczuk JO, Jóźwik A, Huang L, Pirgozliev V, Banach M, Battino M. The current use and evolving landscape of nutraceuticals. Pharmacological Research. 2022 Jan 1;175:106001.
21. Rajat S, Manisha S, Robin S, Sunil K. Nutraceuticals: A review. Int. Res. J. Pharm. 2012;3(4):95-9.
22. Golla U. Emergence of nutraceuticals as the alternative medications for pharmaceuticals. IJCAM. 2018;11:155-8.
23. Prabu SL, SuriyaPrakash TN, Kumar CD, SureshKumar S, Ragavendran T. Nutraceuticals: A review. Elixir Pharm. 2012 Apr 25;46:8372-7.
24. Ruchi S. Role of nutraceuticals in health care: A review. International Journal of Green Pharmacy (IJGP). 2017 Oct 16;11(03).
25. Mishra R, Shuaib M, Mishra PS. A review on herbal antidiabetic drugs (2000-2010). Journal of Applied Pharmaceutical Science. 2011 Aug 30(Issue):235-7.
26. Patel P, Harde P, Pillai J, Darji N, Patel B. Antidiabetic herbal drugs a review. Pharmacophore. 2012;3(1-2012):18-29.
27. Rai MK. A review on some antidiabetic plants of India. Ancient Science of Life. 1995 Jan 1;14(3):168-80.
28. Ediriweera ER, Ratnasooriya WD. A review on herbs used in treatment of diabetes mellitus by Sri Lankan ayurvedic and traditional physicians. Ayu. 2009 Oct 1;30(4):373-91.
29. Murudkar PH, Tambe MS, Chandrasekar SB, Boddeda B, Pawar AT. Common Ayurvedic, Chinese traditional and Unani antidiabetic formulations-a review. Frontiers in Pharmacology. 2022 Oct 12;13:991083.
30. Dwivedi C, Daspaul S. Antidiabetic herbal drugs and polyherbal formulation used for diabetes: A review. J Phytopharmacol. 2013;2(3):44-51.
31. Saravanamuttu S, Sudarsanam D. Antidiabetic plants and their active ingredients: A review. Int J Pharm Sci Res. 2012 Oct 1;3(10):3639.
32. Yadav K, Gawai NM, Shivhare B, Vijapur LS, Tiwari G. Development and evaluation of herbal-enriched nutraceutical gummies for pediatric health. Pharmacognosy Research. 2024;16(4).
33. Karole S, Shrivastava S, Thomas S, Soni B, Khan S, Dubey J, Dubey SP, Khan N, Jain DK. Polyherbal Formulation Concept for Synergic Action: A Review. Journal of Drug Delivery & Therapeutics. 2019 Jan 2.
34. Dengane DR, Vishwasrao AR, Khaladkar MS. Review of Antidiabetic Gummies Formulation using Herbal Drugs: Efficacy, Formulation Techniques, and Future Prospects.
35. Devi DD, Darsih C, Yuniarti N, Ardiningtyas B, Laksitorini MD. Formulation and antioxidant activity of gotu kola jelly candy with plant-based polymers as a gelling agent. Majalah Obat Tradisional. 2024;29(3):266-75.
36. Hedaoo M, Patil-Bhole T, Sharma R, Mahajan M. Exploratory quasi-experimental study of anti-arthritic activity of Ayurvedic polyherbal formulation, Abha Guggulu in osteoarthritis patients. Drug Metabolism and Personalized Therapy. 2023 Sep 15;38(3):281-8.
37. Mastiholimath VS. Development and evaluation of polyherbal formulations for antidiabetic and antiphypertensive activities (Master's thesis, Rajiv Gandhi University of Health Sciences (India)).
38. Niknam S, Tofighi Z, Faramarzi MA, Abdollahifar MA, Sajadi E, Dinarvand R, Toliyat T. Polyherbal combination for wound healing: Matricaria chamomilla L. and Punica granatum L. DARU Journal of Pharmaceutical Sciences. 2021 Jun;29(1):133-45.
39. Kumar T, Gupta SK, Prajapati MK, Tripathi D. Natural excipients: A review. Asian J Pharm Life Sci. 2012;2231:4423.
40. Sopyan IY, Gozali DO, Insan Sunan KS, Guntina RK. Overview of pectin as an excipient and its use in the pharmaceutical dosage form. International Journal of Applied Pharmaceutics. 2022;14(4):64-70.
41. Bagal‐Kestwal DR, Pan MH, Chiang BH. Properties and applications of gelatin, pectin, and carrageenan gels. Bio monomers for green polymeric composite materials. 2019 Sep 30:117-40.
42. Singh P, Mishra G, Dinda SC. Natural excipients in pharmaceutical formulations. InEvidence based validation of traditional medicines: a comprehensive approach 2021 Jan 19 (pp. 829-869). Singapore: Springer Singapore.